CAI FY 2023 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$306M+18.4% YoY

Gross Profit

$89M29.2% margin

Operating Income

-$320M-104.4% margin

Net Income

-$341M-111.5% margin

EPS (Diluted)

$-1.82

Cash Flow

Operating Cash Flow

-$276M

Free Cash Flow

-$298M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$413M

Total Liabilities

$2.6B

Stockholders' Equity

-$2.1B

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$306M	$258M	+18.4%
Gross Profit	$89M	$80M	+11.6%
Operating Income	-$320M	-$316M	-1.2%
Net Income	-$341M	-$321M	-6.4%